What we do Thyrocare Technologies Ltd provides affordable quality diagnostic and preventive healthcare services through an extensive pan-India lab and service network. |
Founded in 2,000 |
Market share Leading diagnostic service provider in India with 25 regional labs, 7,900+ franchisees, and expanding international presence. |
Problem solved Offers early disease detection, preventive care, and ongoing monitoring with accurate, timely diagnostic testing to improve patient health outcomes. |
Top clients or who we serve Works with hospitals, clinics, diagnostic centers, nursing homes, insurance companies; primarily B2B and also B2C through franchises. |
Key management Rahul Guha, Managing Director & CEO with extensive leadership experience in healthcare diagnostics. |
Our journey and innovations Founded in 2000, pioneered centralized automated testing labs, expanded regional labs, launched Aarogyam preventive packages, acquired subsidiaries like Nueclear and Think Health, and expanded globally. |
Where we operate India-wide operations across 32 states, 555 cities; international JV in Tanzania; subsidiary imaging centers in major cities. |
Top products or what we offer Diagnostic testing services offering 920+ tests and 43 health profiles under Aarogyam brand, imaging services including PET-CT scans. |
Top brands Aarogyam preventive health test series (#1 in preventive diagnostics), Jaanch lifestyle health packages, Think Health ECG at-home service. |
Raw materials needed Diagnostic reagents, test kits, laboratory consumables sourced from leading healthcare suppliers. |
Raw materials supplier International and Indian healthcare brands supplying testing instruments and consumables. |
Recurring vs cyclical contribution Most revenue is recurring from testing services with steady demand in healthcare diagnostics. |
Our industry position Market leader in Indian diagnostic testing with high-quality automated labs and wide franchise network. |
Financial highlights FY 2024-25 revenue Rs. 687 crores with net profit Rs. 91.5 crores; 18% CAGR in revenue over recent years. |
Geographical revenue split Predominantly India with increasing contribution from Tanzania JV and imaging subsidiaries. |
Order book - |
Whats driving growth Growth driven by expanding preventive care offerings, network expansion, increasing sample volumes, and new service launches like ECG at home. |
Our future plans Expand lab footprint, increase NABL accreditations, grow international JV, and enhance service portfolio including digital health solutions. |
Our green promise Committed to sustainability via NABL-accredited labs and ethical corporate governance. |
Our people and values Emphasizes strong corporate governance, employee welfare, and an inclusive work culture with 7,900+ active franchisees. |
Key challenges ahead Risks include regulatory changes, competition, and macroeconomic impacts on healthcare expenditure. |
Interesting facts Received highest oversubscription for healthcare IPO; first in India to launch Troponin I heart attack risk test. |
Risks and strategy Emphasizes quality accreditation, partnerships, and technology upgrades to mitigate regulatory and competitive risks. |
